Efficacy of stanozolol and danazol in the treatment of non-severe aplastic anemia and their effects on CD4(+)CD25(+)Foxp3(+) regulatory T cells.
10.3760/cma.j.issn.0253-2727.2022.02.013
- Author:
Hong Min LI
1
;
Zhang Biao LONG
1
;
Tao WANG
2
;
Bing HAN
1
Author Information
1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
2. Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Anemia, Aplastic/drug therapy*;
CD4-Positive T-Lymphocytes;
Danazol;
Forkhead Transcription Factors;
Humans;
Interleukin-2 Receptor alpha Subunit;
Stanozolol;
T-Lymphocytes, Regulatory;
Transcription Factors
- From:
Chinese Journal of Hematology
2022;43(2):157-160
- CountryChina
- Language:Chinese
